| Name | Title | Contact Details |
|---|
Electro-Biology, Inc. is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OXiGENE is a biopharmaceutical company developing new and improved therapeutics that have the potential to deliver significant medical benefits to patients with cancer and serious medical conditions. Our primary focus is developing first-in-class anti-vascular drugs referred to as vascular disrupting agents (VDAs). Our lead compound in clinical development is fosbretabulin. VDAs are a new and highly differentiated class of anti-vascular drug that target existing tumor vasculature, leading to extensive tumor cell death. VDAs target the tumor vasculature rather than the tumor cells and therefore have broad potential therapeutic utility in cancer. Because VDAs act differently than anti-angiogenic drugs or cytotoxic chemotherapy drugs, VDAs are potentially complementary with anti-angiogenic drugs and chemotherapeutic agents. OXiGENE has ongoing VDA drug development programs and is committed to advancing the science of VDAs and their potential as innovative therapies to address unmet medical needs.
Orsini Healthcare is a Elk Grove Village, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 1985, Clinical Research Dental is the proud Canadian distributor for a number of internationally renowned dental manufacturers, including Clinician`s Choice, Ultradent, Bioclear, 3M, Cosmedent, Triodent, Komet and Ribbond. The company is also a leading provider of continuing education programs for dentists, and hosts 40 to 50 seminars and hands-on courses across Canada each year.
Founded in 2005, ZELTIQ is a global medical technology company that developed its patented, non-invasive, and clinically proven CoolSculpting Procedure to selectively reduce exercise-resistant fat bulges.